Description
Relvar Ellipta 200/25mcg provides 30 daily doses of powerful maintenance therapy for adults and adolescents managing asthma or Chronic Obstructive Pulmonary Disease (COPD). This advanced dry powder inhaler combines a higher dose of Fluticasone Furoate (200mcg), an inhaled corticosteroid that potently reduces airway inflammation, with Vilanterol (25mcg), a long-acting beta2-agonist that consistently relaxes and widens the air passages. Used once daily, Relvar Ellipta 200/25mcg offers enhanced control over respiratory symptoms, helps prevent exacerbations, and significantly improves lung function, enabling more comfortable breathing and an improved quality of life. (Note: This medication is for daily maintenance, not for acute breathing problems.)
